Production Bases
.jpg)
Kvvit Manufacturing Center·Chemical Drug Production Base
Located in Zhanggong High‑tech Zone, Ganzhou City, Jiangxi Province, the base covers an area of 306,667 square meters with a total construction area of 300,000 square meters. Designed and constructed in compliance with US CGMP and EU GMP standards, it features highly automated and intelligent pharmaceutical production processes with continuous and flexible manufacturing capacity. It ranks among the largest, highest-standard and most complete industrialization bases for biopharmaceuticals in central China. Drugs Produced: Suraxavir Marboxil Tablets, Brivaracetam, Mecobalamin Tablets, Entecavir Capsules / Dispersible Tablets, etc.
- 4.5 billion tabletsAnnual Production Capacity of Tablets
- 1 billion capsulesAnnual Production Capacity of Capsules
Shanxiang Manufacturing Center·Special Preparations Production Base
Located in Ganzhou Economic and Technological Development Zone, Jiangxi Province, the base covers an area of more than 66666.67 square meters. It undertakes the commercial production of special formulations for KVVIT Pharmaceutical, including sustained and controlled-release oral tablets and capsules. It features three major technical platforms: pellet compression, osmotic pump, and hot melt extrusion. The base is capable of commercial production of hormonal drugs and OEB5-class anti-tumor medicines. Its annual production capacity reaches 2 billion tablets and 500 million sachets of granules. Products: Esomeprazole Magnesium Enteric-coated Tablets, Rabeprazole Sodium Enteric-coated Tablets, Olaparib Tablets, etc.
- 2 billion tabletsAnnual Production Capacity of Tablets
- 500 million sachetsAnnual Production Capacity of Granules
API Manufacturing Center·Raw Material Production Base
The base is equipped with general API workshops, anti-tumor API workshops and hydrogenation workshops, with more than ten production lines. It supports the transfer and industrialization of research pipeline products, as well as the production of launched APIs. Representative Products: More than 30 drug substances including Sorafenib Tosylate, Brivaracetam, Rasagiline, Evocalcet and Palbociclib.
- 70 tonsAnnual API Production Capacity
Pharmaceutical Production Lines
Advanced tableting and packaging equipment imported from Germany enables intelligent full-process material handling. Boasting domestically leading production efficiency, it ranks among the most advanced solid dosage form production lines in China.
It is equipped with domestically leading facilities such as integrated washing-drying-filling-sealing machines for oral liquids, automatic visual inspection machines, labeling machines, fully automatic cartoning machines and integrated case opening-packing- sealing machines. It realizes one-stop full-process production with the advantages of high speed, large output and controllable quality.
.jpg)
It houses workshops for non-terminally sterilized ampoules, terminally sterilized ampoules, and non-terminally sterilized vials (lyophilized). All workshops adopt advanced domestic production equipment with fully automatic operation, ensuring stable and controllable product quality.
.jpg)
The production lines undertake the commercial manufacturing of special formulations including pellets, osmotic pump systems and hot melt extrusion products. Key production and testing equipment reaches the leading domestic level with a high degree of standardization, supporting continuous and flexible production capacity.
The workshops are equipped with OEB5-grade feeding isolators and DCS automatic control systems, capable of meeting API production requirements for different stages and batch sizes.
Advanced tableting and packaging equipment imported from Germany enables intelligent full-process material handling. Boasting domestically leading production efficiency, it ranks among the most advanced solid dosage form production lines in China.
It is equipped with domestically leading facilities such as integrated washing-drying-filling-sealing machines for oral liquids, automatic visual inspection machines, labeling machines, fully automatic cartoning machines and integrated case opening-packing- sealing machines. It realizes one-stop full-process production with the advantages of high speed, large output and controllable quality.
It houses workshops for non-terminally sterilized ampoules, terminally sterilized ampoules, and non-terminally sterilized vials (lyophilized). All workshops adopt advanced domestic production equipment with fully automatic operation, ensuring stable and controllable product quality.
The production lines undertake the commercial manufacturing of special formulations including pellets, osmotic pump systems and hot melt extrusion products. Key production and testing equipment reaches the leading domestic level with a high degree of standardization, supporting continuous and flexible production capacity.
The workshops are equipped with OEB5-grade feeding isolators and DCS automatic control systems, capable of meeting API production requirements for different stages and batch sizes.
